Achelios Therapeutics Overview
- Year Founded
-
2012
- Status
-
Private
- Employees
-
6
- Latest Deal Type
-
Series B
- (Cancelled)
- Latest Deal Amount
-
$11M
- Investors
-
3
Achelios Therapeutics General Information
Description
Developer of pharmaceutical products designed to reformulate non-steroidal anti-inflammatory drug molecules as topically delivered medications. The company's technology focuses on therapeutic compound development for the treatment of sprains, migraine prophylaxis, osteoarthritis, and strains by decreasing side effects and improving efficacy, enabling patients to receive faster and improved pain relief.
Contact Information
Website
www.achelios.comCorporate Office
- 4364 South Alston Avenue
- Suite 300
- Durham, NC 27713
- United States
Corporate Office
- 4364 South Alston Avenue
- Suite 300
- Durham, NC 27713
- United States
Achelios Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Later Stage VC (Series B) | 01-Feb-2021 | $11M | Cancelled | Clinical Trials - Phase 2 | ||
| 4. Later Stage VC (Series A1) | 01-Oct-2020 | Completed | Clinical Trials - Phase 2 | |||
| 3. Debt - General | 14-Apr-2020 | Completed | Clinical Trials - Phase 2 | |||
| 2. Seed Round | 13-Mar-2014 | $3.17M | $5.17M | Completed | Clinical Trials - Phase 1 | |
| 1. Capitalization | 02-Feb-2012 | $2M | $2M | Completed | Pre-Clinical Trials |
Achelios Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A1 | ||||||||
| Series A |
Achelios Therapeutics Comparisons
Industry
Financing
Details
Achelios Therapeutics Competitors (28)
One of Achelios Therapeutics’s 28 competitors is Johnson&Johnson Innovative Medicine, a Venture Capital-Backed company based in Raritan, NJ.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Johnson&Johnson Innovative Medicine | Venture Capital-Backed | Raritan, NJ | ||||
| Pfizer (Vienna) | Corporation | Vienna, Austria | ||||
| EnGeneIC | Formerly VC-backed | Sydney, Australia | ||||
| Dicerna Pharmaceuticals | Formerly VC-backed | Lexington, MA | ||||
| Genentech | Formerly VC-backed | South San Francisco, CA |
Achelios Therapeutics Patents
Achelios Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2017325726-A1 | Topical anti-inflammatory compositions | Active | 16-Sep-2016 | ||
| AU-2017325726-B2 | Topical anti-inflammatory compositions | Active | 16-Sep-2016 | ||
| EP-3512498-A1 | Topical anti-inflammatory compositions | Active | 16-Sep-2016 | ||
| EP-3512498-A4 | Topical anti-inflammatory compositions | Active | 16-Sep-2016 | ||
| EP-3512498-B1 | Topical anti-inflammatory compositions | Active | 16-Sep-2016 | A61K31/196 |
Achelios Therapeutics Signals
Achelios Therapeutics Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Angel (individual) | Minority | |||
| Keiretsu Forum | Angel Group | Minority | ||
| K2X | Venture Capital | Minority |
Achelios Therapeutics FAQs
-
When was Achelios Therapeutics founded?
Achelios Therapeutics was founded in 2012.
-
Where is Achelios Therapeutics headquartered?
Achelios Therapeutics is headquartered in Durham, NC.
-
What is the size of Achelios Therapeutics?
Achelios Therapeutics has 6 total employees.
-
What industry is Achelios Therapeutics in?
Achelios Therapeutics’s primary industry is Drug Delivery.
-
Is Achelios Therapeutics a private or public company?
Achelios Therapeutics is a Private company.
-
What is the current valuation of Achelios Therapeutics?
The current valuation of Achelios Therapeutics is .
-
What is Achelios Therapeutics’s current revenue?
The current revenue for Achelios Therapeutics is .
-
How much funding has Achelios Therapeutics raised over time?
Achelios Therapeutics has raised $24.7M.
-
Who are Achelios Therapeutics’s investors?
, Keiretsu Forum, and K2X have invested in Achelios Therapeutics.
-
Who are Achelios Therapeutics’s competitors?
Johnson&Johnson Innovative Medicine, Pfizer (Vienna), EnGeneIC, Dicerna Pharmaceuticals, and Genentech are some of the 28 competitors of Achelios Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process